Rare genetic headache

Rare genetic headache (Orphanet code 183509) is a broad classification used by Orphanet to group uncommon headache disorders that have a demonstrated or suspected genetic basis. This category encompasses a heterogeneous set of conditions in which headache is the primary or a prominent clinical feature, and where a monogenic or strong genetic contribution has been identified. These disorders affect the nervous system, particularly the cerebrovascular and neurological pathways involved in pain signaling, and may involve dysfunction of ion channels, vascular structures, or other neural mechanisms. Conditions grouped under this umbrella may include entities such as familial hemiplegic migraine (caused by mutations in CACNA1A, ATP1A2, or SCN1A genes), CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, caused by NOTCH3 mutations), and other monogenic headache syndromes. Symptoms vary depending on the specific underlying condition but commonly include recurrent severe headaches, migraine with or without aura, and in some cases neurological deficits such as hemiplegia, visual disturbances, cognitive decline, or stroke-like episodes. Some conditions in this group may also feature systemic vascular involvement. Treatment for rare genetic headaches is largely symptomatic and supportive, as no curative therapies currently exist for most of these conditions. Management may include acute and preventive migraine medications (such as triptans, though these are contraindicated in some subtypes like hemiplegic migraine), antiepileptic drugs, calcium channel blockers, and lifestyle modifications. Genetic counseling is recommended for affected individuals and their families. Because this is a grouping category rather than a single disease entity, clinical features, inheritance, and prognosis vary significantly depending on the specific diagnosis within this classification.

Common questions about Rare genetic headache